Ikena Oncology Inc reports results for the quarter ended in December - Earnings Summary

ImageneBio

15/03/2023 12:00

* Ikena Oncology Inc  IKNA.OQ  reported a quarterly adjusted
loss
of 40 cents​​ per share for the quarter ended in December. The
mean expectation of five analysts for the quarter was for a loss
of 48 cents per share.
    * Revenue fell 73% to $5.45 million from a year ago;
analysts
expected $6.02 million. 
    * Ikena Oncology Inc's reported EPS for the quarter was a
loss
of 40 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Ikena Oncology Inc shares had risen by 58.3% this quarter.
    * The company reported a quarterly loss of $14.1 million.
    * Wall Street's median 12-month price target for Ikena
Oncology
Inc is $22.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 15 at 12:00 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.48          -0.40          Beat
 Sep. 30 2022      -0.50          -0.48          Beat
 Jun. 30 2022      -0.49          -0.57          Missed
 Mar. 31 2022      -0.42          -0.47          Missed